Morphometric evaluation revealed that, the mean percentage of immune cells positive for PD-1, or LAG3 or T-bet was higher (p<0.001) in CRC samples from short-term survivors, than in tumor samples from long-term survivors, as reported in the Table 6. The gene discussed is PDCD1; the disease is neoplasm.